輸液・ンプ、インフュージョン・ンプ

WordNet

supply in great quantities; "Pump money into a project"
a low-cut shoe without fastenings
a mechanical device that moves fluid or gas by pressure or suction
deliver forth; "pump bullets into the dummy"
draw or pour with a pump
flow intermittently
move up and down; "The athlete pumps weights in the gym"
operate like a pump; move up and down, like a handle or a pedal; "pump the gas pedal"
question persistently; "She pumped the witnesses for information"
raise (gases or fluids) with a pump
a solution obtained by steeping or soaking a substance (usually in water) (同)extract
the process of extracting certain active properties (as a drug from a plant) by steeping or soaking (usually in water)
(medicine) the passive introduction of a substance (a fluid or drug or electrolyte) into a vein or between tissues (as by gravitational force)
the act of infusing or introducing a certain modifying element or quality; "the teams continued success is attributable to a steady infusion of new talent"

PrepTutorEJDIC

『ポンプ』 / 《単数形で》ポンプで空気(ガス)を入れること / 《副詞[句]を伴って》〈気体・液体〉‘を'『ポンプで入れる』(『出す』) / …‘から'ポンプで水(など)を除く《+『out』+『名』,+『名』+『out』》 / …‘に'ポンプで空気(など)を満たす《+『up』+『名』,+『名』+『up』》 / (ポンプのハンドルのように)…‘を'上下(前後)に動かす / 《話》(…について)〈人〉‘を'あの手この手で問いただす(聞き出す)《+『名』+『for』(『about』)+『名』》 / 《話》(人に)〈知識など〉‘を'詰め込む《+『名』+『into』+『名』〈人〉》;(人から)〈情報など〉‘を'引き出す《+『名』+『out of』+『名』〈人〉》 / ポンプを使う / (ポンプのように)上下に動く,鼓動する / 〈水が〉噴出する
パンプス(ひもや金具がなく,甲のあいた靴)
〈U〉(…を…に)教え込むこと,(…の)鼓吹,注入《+『of』+『名』+『into』+『名』》 / 〈C〉水(湯)に浸してできたもの;振り出し汁

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/06/23 17:11:59」(JST)

wiki en

[Wiki en表示]

A type of infusion pump, manufactured by Fresenius.

An infusion pump infuses fluids, medication or nutrients into a patient's circulatory system. It is generally used intravenously, although subcutaneous, arterial and epidural infusions are occasionally used.

Infusion pumps can administer fluids in ways that would be impractically expensive or unreliable if performed manually by nursing staff. For example, they can administer as little as 0.1 mL per hour injections (too small for a drip), injections every minute, injections with repeated boluses requested by the patient, up to maximum number per hour (e.g. in patient-controlled analgesia), or fluids whose volumes vary by the time of day.

Because they can also produce quite high but controlled pressures, they can inject controlled amounts of fluids subcutaneously (beneath the skin), or epidurally (just within the surface of the central nervous system- a very popular local spinal anesthesia for childbirth).

Types of infusion

The user interface of pumps usually requests details on the type of infusion from the technician or nurse that sets them up:

Continuous infusion usually consists of small pulses of infusion, usually between 500 nanoliters and 10 milliliters, depending on the pump's design, with the rate of these pulses depending on the programmed infusion speed.
Intermittent infusion has a "high" infusion rate, alternating with a low programmable infusion rate to keep the cannula open. The timings are programmable. This mode is often used to administer antibiotics, or other drugs that can irritate a blood vessel.
Patient-controlled is infusion on-demand, usually with a preprogrammed ceiling to avoid intoxication. The rate is controlled by a pressure pad or button that can be activated by the patient. It is the method of choice for patient-controlled analgesia (PCA), in which repeated small doses of opioid analgesics are delivered, with the device coded to stop administration before a dose that may cause hazardous respiratory depression is reached.
Total parenteral nutrition usually requires an infusion curve similar to normal mealtimes.

Some pumps offer modes in which the amounts can be scaled or controlled based on the time of day. This allows for circadian cycles which may be required for certain types of medication.

Types of pump

A Baxter International Colleague CX infusion pump

There are two basic classes of pumps. Large volume pumps can pump nutrient solutions large enough to feed a patient. Small-volume pumps infuse hormones, such as insulin, or other medicines, such as opiates.

Within these classes, some pumps are designed to be portable, others are designed to be used in a hospital, and there are special systems for charity and battlefield use.

Large-volume pumps usually use some form of peristaltic pump. Classically, they use computer-controlled rollers compressing a silicone-rubber tube through which the medicine flows. Another common form is a set of fingers that press on the tube in sequence.

Small-volume pumps usually use a computer-controlled motor turning a screw that pushes the plunger on a syringe.

The classic medical improvisation for an infusion pump is to place a blood pressure cuff around a bag of fluid. The battlefield equivalent is to place the bag under the patient. The pressure on the bag sets the infusion pressure. The pressure can actually be read-out at the cuff's indicator. The problem is that the flow varies dramatically with the patient's blood pressure (or weight), and the needed pressure varies with the administration route, potentially causing risk when attempted by an individual not trained in this method.

Places that must provide the least-expensive care often use pressurized infusion systems. One common system has a purpose-designed plastic "pressure bottle" pressurized with a large disposable plastic syringe. A combined flow restrictor, air filter and drip chamber helps a nurse set the flow. The parts are reusable, mass-produced sterile plastic, and can be produced by the same machines that make plastic soft-drink bottles and caps. A pressure bottle, restrictor and chamber requires more nursing attention than electronically controlled pumps. In the areas where these are used, nurses are often volunteers, or very inexpensive.

The restrictor and high pressure helps control the flow better than the improvised schemes because the high pressure through the small restrictor orifice reduces the variation of flow caused by patients' blood pressures.

An air filter is an essential safety device in a pressure infusor, to keep air out of the patients' veins: doctors estimate that 0.55 cm³ of air per kilogram of body weight is enough to kill (200–300 cm³ for adults) by filling the patient's heart. Small bubbles could cause harm in arteries, but in the veins they pass through the heart and leave in the patients' lungs. The air filter is just a membrane that passes gas but not fluid or pathogens. When a large air bubble reaches it, it bleeds off.

Some of the smallest infusion pumps use osmotic power. Basically, a bag of salt solution absorbs water through a membrane, swelling its volume. The bag presses medicine out. The rate is precisely controlled by the salt concentrations and pump volume. Osmotic pumps are usually recharged with a syringe.

Spring-powered clockwork infusion pumps have been developed, and are sometimes still used in veterinary work and for ambulatory small-volume pumps. They generally have one spring to power the infusion, and another for the alarm bell when the infusion completes.

Battlefields often have a need to perfuse large amounts of fluid quickly, with dramatically changing blood pressures and patient condition. Specialized infusion pumps have been designed for this purpose, although they have not been deployed.

Many infusion pumps are controlled by a small embedded system. They are carefully designed so that no single cause of failure can harm the patient. For example, most have batteries in case the wall-socket power fails. Additional hazards are uncontrolled flow causing an overdose, uncontrolled lack of flow, causing an underdose, reverse flow, which can siphon blood from a patient, and air in the line, which can cause an air embolism.

Safety features available on some pumps

The range of safety features varies widely with the age and make of the pump. A state of the art pump in 2003^[update] may have the following safety features:

Certified to have no single point of failure. That is, no single cause of failure should cause the pump to silently fail to operate correctly. It should at least stop pumping and make at least an audible error indication. This is a minimum requirement on all human-rated infusion pumps of whatever age. It is not required for veterinary infusion pumps.
Batteries, so the pump can operate if the power fails or is unplugged.
Anti-free-flow devices prevent blood from draining from the patient, or infusate from freely entering the patient, when the infusion pump is being set up.
A "down pressure" sensor will detect when the patient's vein is blocked, or the line to the patient is kinked. This may be configurable for high (subcutaneous and epidural) or low (venous) applications.
An "air-in-line" detector. A typical detector will use an ultrasonic transmitter and receiver to detect when air is being pumped. Some pumps actually measure the volume, and may even have configurable volumes, from 0.1 to 2 ml of air. None of these amounts can cause harm, but sometimes the air can interfere with the infusion of a low-dose medicine.
An "up pressure" sensor can detect when the bag or syringe is empty, or even if the bag or syringe is being squeezed.
A drug library with customizable programmable limits for individual drugs that helps to avoid medication errors.
Mechanisms to avoid uncontrolled flow of drugs in large volume pumps (often in combination with a giving st based free flow clamp) and increasingly also in syringe pumps (piston-brake)
Many pumps include an internal electronic log of the last several thousand therapy events. These are usually tagged with the time and date from the pump's clock. Usually, erasing the log is a feature protected by a security code, specifically to detect staff abuse of the pump or patient.
Many makes of infusion pump can be configured to display only a small subset of features while they are operating, in order to prevent tampering by patients, untrained staff and visitors.

Safety issues

Infusion pumps have been a source of multiple patient safety concerns, and problems with such pumps have been linked to more than 56,000 adverse event reports from 2005 to 2009, including at least 500 deaths.^[1] As a result, the U.S. Food and Drug Administration (FDA) has launched a comprehensive initiative to improve their safety, called the Infusion Pump Improvement Initiative.^[2] The initiative proposed stricter regulation of infusion pumps. It cited software defects, user interface issues, and mechanical or electrical failures as the main causes of adverse events.

References

^ Pharmacy Practice News, May 2010
^ http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/GeneralHospitalDevicesandSupplies/InfusionPumps/ucm205424.htm

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 大腸癌の肝転移に対する非外科的局所治療戦略 nonsurgical local treatment strategies for colorectal cancer liver metastases

English Journal

A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients.

Naimi RM, Madsen KB, Askov-Hansen C, Brandt CF, Hartmann B, Holst JJ, Mortensen PB, Jeppesen PB.SourceDepartment of Gastroenterology CA-2121, Rigshospitalet, Copenhagen University Hospital, Denmark.
Regulatory peptides.Regul Pept.2013 Jun 10;184:47-53. doi: 10.1016/j.regpep.2013.03.023. Epub 2013 Mar 15.
OBJECTIVE: Glucagon-like peptide 2 (GLP-2), secreted endogenously from L-cells in the distal bowel in relation to meals, modulates intestinal absorption by adjusting gastric emptying and secretion and intestinal growth. Short bowel syndrome (SBS) patients with distal intestinal resections have atten
PMID 23501043

Using higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactam.

Lam WJ, Bhowmick T, Gross A, Vanschooneveld TC, Weinstein MP.SourceRutgers University Ernest Mario School of Pharmacy, Piscataway, NJ; Infectious Diseases Clinical Specialist, Robert Wood Johnson University Hospital, New Brunswick, NJ.
The Annals of pharmacotherapy.Ann Pharmacother.2013 Jun;47(6):886-91. doi: 10.1345/aph.1R721. Epub 2013 May 28.
OBJECTIVE: To mathematically assess drug losses due to infusion line residuals and evaluate methods to compensate for drug loss due to residual volumes in intravenous pump tubing.DATA SOURCES: Literature was accessed through Ovid MEDLINE (1996-February 2013), using combinations of the search terms t
PMID 23715072

Impact of propofol on mid-latency auditory-evoked potentials in children.

Kuhnle GE, Hornuss C, Lenk M, Salam AP, Wiepcke D, Edelmann-Gahr V, Flake G, Daunderer M, Oberhauser M, Müller HH, Feuerecker M.SourceClinic of Anaesthesiology, SRH Wald-Klinikum Gera GmbH, Straße des Friedens 122, 07548 Gera, Germany.
British journal of anaesthesia.Br J Anaesth.2013 Jun;110(6):1001-9. doi: 10.1093/bja/aet002. Epub 2013 Feb 10.
BACKGROUND: /st> Propofol is increasingly used in paediatric anaesthesia, but can be challenging to titrate accurately in this group. Mid-latency auditory-evoked potentials (MLAEPs) can be used to help titrate propofol. However, the effects of propofol on MLAEP in children are unclear. Therefore,
PMID 23399557

Japanese Journal

Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan

LIN Chia-Hung,HUANG Chung-Huei,TSAI Jir-Shiong,HSIEH Sheng-Hwu,SUN Jui-Hung,HUANG Bie-Yui,HUANG Miau-Ju,HUANG Yu-Yao
Endocrine journal 58(10), 835-840, 2011-10-01
NAID 10029862995

Effect of Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients With Recent Exposure to Dual Antiplatelet Therapy Undergoing Off-Pump Coronary Artery Bypass Graft Surgery

LEE Jeong Soo,AHN So Woon,SONG Jong Wook,SHIM Jae Kwang,YOO Kyung-Jong,KWAK Young Lan
Circulation journal : official journal of the Japanese Circulation Society 75(10), 2397-2402, 2011-09-25
… As the indications for clopidogrel expand, an increasing number of patients undergoing off-pump coronary artery bypass surgery (OPCAB) are also undergoing dual antiplatelet therapy (DAPT), with its higher risk of bleeding complications. … Methods and Results: Patients who received clopidogrel and aspirin within 5 days of OPCAB were randomly allocated to receive HES 130/0.4 (≤30ml/kg) followed by crystalloid infusion (HES group, n=53), or crystalloid only (crystalloid group, n=53) perioperatively. …
NAID 10029459461